bioAffinity Licenses CyPath(R) Lung to Precision Pathology Services
SAN ANTONIO, Oct. 10, 2018 -- (Healthcare Sales & Marketing Network) -- bioAffinity Technologies, a privately held biotech company, today announced a licensing agreement with Precision Pathology Services for the continued development and commercial sale of... Diagnostics, Oncology, Licensing bioAffinity Technologies, Precision Pathology Services, CyPath Lung, lung cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Lung Cancer | Marketing | Pathology | Pharmaceuticals